Results 211 to 220 of about 182,132 (342)
Targeted Degradation of sGRP78 Alleviates the Immunosuppressive Tumor Microenvironment
Soluble GRP78 (sGRP78) is identified as a novel tumor‐derived soluble factor that induces regulatory T cells (Treg). sGRP78 serves as an excellent serological biomarker for predicting the efficacy of neoadjuvant therapy in breast cancer patients. sGRP78 specifically binds to B cells, inducing the expression of IL‐10 and PD‐L1, thereby promoting Treg ...
Zhenghao Wu +10 more
wiley +1 more source
Senescent bone marrow mesenchymal stem cells (BMSCs) exhibit increased sensitivity to ferroptosis, a phenomenon associated with Steap4, a nicotinamide adenine dinucleotide phosphate hydrogen (NADPH)‐dependent metalloreductase that reduces Fe3+ to Fe2+.
Liangliang Wang +9 more
wiley +1 more source
Exosomes: A Promising Cell-Free Therapeutic Tool for Treating Cutaneous Nerve Injuries and Promoting Wound Healing [PDF]
Yujie Mu +7 more
openalex +1 more source
CircSMPD4 physically combines with lactate dehydrogenase A (LDHA) and reduces its acetylation level via SIRT2‐dependent deacetylation, thereby inhibiting chaperone‐mediated autophagy‐lysosome degradation of LDHA. Upregulating LDHA leads to increasing lactate production and extracellular export, which in turn suppresses natural killer cell cytotoxicity ...
Hao Shen +16 more
wiley +1 more source
The effect of exosome-related therapy in cardiac revascularization procedures: a systematic review. [PDF]
Shojaei S +6 more
europepmc +1 more source
List of proteins identified by mass spectrometry in PAN02 exosomes.
Costa-silva Bruno
openalex +1 more source
In HCC, circZNF79(5) binds to YBX1 and functions as an oncogene, recruits BRCC36 to remove K63‐linked ubiquitin chains to stabilize YBX1 protein, and promotes HCC progression via the HIF‐1 signaling pathway. Conversely, circZNF79(5) silencing activates the AMPK/mTOR pathway, inducing p62‐mediated selective autophagic degradation of YBX1.
Xueqiang Guo +20 more
wiley +1 more source
Implication of an exosome-based gene signature for estimating clinical outcomes of triple-negative breast cancer and assisting in individualized therapy. [PDF]
Yang Q +6 more
europepmc +1 more source
PS1129 CLL‐ DERIVED EXOSOMES REPROGRAM RESIDENT CELLS TO BECOME CLL SUPPORTIVE CELLS
Orit Uziel +6 more
openalex +1 more source

